Speaker illustration

Professor Jan-Malte Sinning

St. Vinzenz-Hospital, Cologne (Germany)

Member of:

European Society of Cardiology
EAPCI
Heart Failure Association

Discussion - What challenges do we need to tackle in the future?

Event: ESC Congress 2022

Topic: Treatment

Session: 20 years of TAVI - How can we get to a comprehensive patient management?

Thumbnail

Putting severe aortic stenosis patient management into practice.

Event: ESC Congress 2022

Topic: Treatment

Session: 20 years of TAVI - How can we get to a comprehensive patient management?

Thumbnail

2021 ESC/EACTS VHD guidelines: evolution of treatment recommendations.

Event: ESC Congress 2021 - The Digital Experience

Topic: Aortic Valve Stenosis

Session: The Future of TAVI: How are the new 2021 ESC/EACTS VHD guidelines changing management and treatment of patients with aortic stenosis

Thumbnail

Discussion - Patient selection for protected PCI: who benefits most?

Event: ESC CONGRESS 2019

Topic: Treatment

Session: Recovering hearts - Saving lives

Thumbnail

Reclassification of aortic valve stenosis patients by integration of computed tomography parameters into the echocardiographically assessed continuity equation

Event: ESC CONGRESS 2017

Topic: Aortic valve disease

Session: Multimodality imaging in aortic stenosis

Thumbnail

Hemodynamic stabilization to facilitate complete revascularization.

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Topic: Miscellaneous

Session: How innovative percutaneous Ventricular Assist Device (pVAD) systems improve outcomes in cardiogenic shock and facilitate complete revascularization in high risk Percutaneous Coronary Intervention (PCI) patients

Thumbnail

Next generation transcatheter heart valves improve clinical outcomes in patients undergoing transcatheter aortic valve implantation.

Event: ESC CONGRESS 2016

Topic: Surgery and intervention in valve disease

Session: Valvular disease

Thumbnail

Transcatheter aortic valve replacement with the self-expanding CoreValve prosthesis performed using clinical best practices: impact on clinical outcomes to six months. The ADVANCE II study.

Event: ESC CONGRESS 2016

Topic: Surgery and intervention in valve disease

Session: Aortic valve disease

Thumbnail

ESC 365 is supported by

logo Novo Nordisk